Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001295947-25-000029
Filing Date
2025-08-07
Accepted
2025-08-07 06:15:06
Documents
85
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q pbh-20250630.htm   iXBRL 10-Q 1114764
2 EX-31.1 exhibit3112025-6x30.htm EX-31.1 11105
3 EX-31.2 exhibit3122025-6x30.htm EX-31.2 10990
4 EX-32.1 exhibit3212025-6x30.htm EX-32.1 5293
5 EX-32.2 exhibit3222025-6x30.htm EX-32.2 5208
11 pbh-20250630_g1.jpg GRAPHIC 66137
  Complete submission text file 0001295947-25-000029.txt   7418405

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pbh-20250630.xsd EX-101.SCH 51890
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pbh-20250630_cal.xml EX-101.CAL 110497
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pbh-20250630_def.xml EX-101.DEF 198658
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pbh-20250630_lab.xml EX-101.LAB 693947
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pbh-20250630_pre.xml EX-101.PRE 460665
87 EXTRACTED XBRL INSTANCE DOCUMENT pbh-20250630_htm.xml XML 1099798
Mailing Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591
Business Address 660 WHITE PLAINS RD. TARRYTOWN NY 10591 (914) 524-6800
Prestige Consumer Healthcare Inc. (Filer) CIK: 0001295947 (see all company filings)

EIN.: 201297589 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-32433 | Film No.: 251191402
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)